Eosinophilic and Neutrophilic Airway Inflammation in the Phenotyping of Mild-to-Moderate Asthma and Chronic Obstructive Pulmonary Disease

References

• Culpitt SV, Rogers DF, Traves SL, Barnes PJ, Donnelly LE. Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma. Respir Med 2005; 99(6):703–710.
   PubMed Web of Science ®Google Scholar
• Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G, et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167(3):418–424.
   PubMed Web of Science ®Google Scholar
• Górska K, Maskey-Warzechowska M, Krenke R. Airway inflammation in chronic obstructive pulmonary disease. Curr Opin Pulm Med 2010; 16(2):89–96.
   PubMed Web of Science ®Google Scholar
• Rufo J, Taborda-Barata L, Lourenço O. Serum biomarkers in elderly asthma. J Asthma 2013; 50(10):1011–1019.
   PubMed Web of Science ®Google Scholar
• Holgate ST, Davies DE, Lackie PM, Wilson SJ, Puddicombe SM, Lordan JL. Epithelial-mesenchymal interactions in the pathogenesis of asthma. J Allergy Clin Immunol 2000; 105(2 Pt 1):193–204.
   PubMed Web of Science ®Google Scholar
• Simpson JL, McElduff P, Gibson PG. Assessment and reproducibility of non-eosinophilic asthma using induced sputum. Respiration 2010; 79(2):147–151.
   PubMed Web of Science ®Google Scholar
• Schleich FN, Manise M, Sele J, Henket M, Seidel L, Louis R. Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammation. BMC Pulm Med 2013; 13:11.
   PubMed Web of Science ®Google Scholar
• Wood LG, Baines KJ, Fu J, Scott HA, Gibson PG. The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma. Chest 2012; 142(1):86–93.
   PubMed Web of Science ®Google Scholar
• Saha S, Brightling CE. Eosinophilic airway inflammation in COPD. Int J Chron Obstruct Pulm Dis 2006; 1(1):39–47.
   PubMedGoogle Scholar
• Eltboli O, Mistry V, Barker B, Brightling CE. Relationship between blood and bronchial submucosal eosinophilia and reticular basement membrane thickening in chronic obstructive pulmonary disease. Respirology 2015; 20(4):667–670.
   PubMed Web of Science ®Google Scholar
• Pavord ID, Lettis S, Locantore N, Pascoe S, Jones PW, Wedzicha JA, et al. Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD. Thorax 2016; 71(2):118–125.
   PubMed Web of Science ®Google Scholar
• Siddiqui SH, Guasconi A, Vestbo J, Jones P, Agusti A, Paggiaro P, et al. Blood eosinophils: a biomarker of response to extrafine beclomethasone/formoterol in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2015; 192(4):523–525.
   PubMed Web of Science ®Google Scholar
• Pascoe S, Locantore N, Dransfield MT, Barnes NC, Pavord ID. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med 2015; 3(6):435–442.
   PubMed Web of Science ®Google Scholar
• Bafadhel M, McKenna S, Terry S, Mistry V, Pancholi M, Venge P, et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am J Respir Crit Care Med 2012; 186(1):48–55.
   PubMed Web of Science ®Google Scholar
• Rovina N, Koutsoukou A, Koulouris NG. Inflammation and immune response in COPD: where do we stand? Mediators Inflamm 2013; 2013:413735.
   PubMed Web of Science ®Google Scholar
• Churg A, Zhou S, Wright JL. Series “matrix metalloproteinases in lung health and disease”: matrix metalloproteinases in COPD. Eur Respir J 2012; 39(1):197–209.
   PubMed Web of Science ®Google Scholar
• Lee T-M, Lin M-S, Chang N-C. Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin. Am J Cardiol 2008; 101(4):530–535.
   PubMed Web of Science ®Google Scholar
• Cianchetti S, Bacci E, Ruocco L, Pavia T, Bartoli ML, Cardini C, et al. Are sputum eosinophil cationic protein and eosinophils differently associated with clinical and functional findings of asthma? Clin Exp Allergy J Br Soc Allergy Clin Immunol 2014; 44(5):673–680.
   PubMed Web of Science ®Google Scholar
• Chu DK, Llop-Guevara A, Walker TD, Flader K, Goncharova S, Boudreau JE, et al. IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite and peanut allergic sensitization. J Allergy Clin Immunol 2013; 131(1):187–200.
   PubMed Web of Science ®Google Scholar
• Ghebre MA, Bafadhel M, Desai D, Cohen SE, Newbold P, Rapley L, et al. Biological clustering supports both “Dutch” and “British” hypotheses of asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol 2015; 135(1):63–72.
   PubMed Web of Science ®Google Scholar
• Agusti A, Bel E, Thomas M, Vogelmeier C, Brusselle G, Holgate S, et al. Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J 2016; 47(2):410–419.
   PubMed Web of Science ®Google Scholar
• GINA_Report_2010_1.pdf. February 12, 2016. Available from: http://www.ginasthma.org/local/uploads/files/GINA_Report_2010_1.pdf
   Google Scholar
• GOLDReport_April112011.pdf. February 12, 2016. Available from: http://www.goldcopd.org/uploads/users/files/GOLDReport_April-112011.pdf
   Google Scholar
• Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005; 26(2):319–338.
   PubMed Web of Science ®Google Scholar
• Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26(5):948–968.
   PubMed Web of Science ®Google Scholar
• Position paper. Allergen standardization and skin tests. The European Academy of Allergology and Clinical Immunology. Allergy 1993; 48(14 Suppl):48–82.
   PubMedGoogle Scholar
• Vignola AM, Rennar SI, Hargreave FE, Fah JV, Bonsignore MR, Djukanović R, et al. Standardised methodology of sputum induction and processing. Future directions. Eur Respir J Suppl 2002; 37:51s–55s.
   PubMedGoogle Scholar
• Berry M, Morgan A, Shaw DE, Parker D, Green R, Brightling C, et al. Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax 2007; 62(12):1043–1049.
   PubMed Web of Science ®Google Scholar
• Grubek-Jaworska H, Paplińska M, Hermanowicz-Salamon J, Białek-Gosk K, Dąbrowska M, Grabczak E, et al. IL-6 and IL-13 in induced sputum of COPD and asthma patients: correlation with respiratory tests. Respiration 2012; 84(2):101–107.
   PubMed Web of Science ®Google Scholar
• van Buuren S, Groothuis-Oudshoorn K. mice: Multivariate imputation by chained equations in R. J Stat Software 2011; 45(3):1–67.
   Web of Science ®Google Scholar
• The R Core Team. R. A Language and Environment for Statistical Computing. 2014. Available from: http://www.R-project.org/
   Google Scholar
• Wagener AH, de Nijs SB, Lutter R, Sousa AR, Weersink EJM, Bel EH, et al. External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma. Thorax 2015; 70(2):115–120.
   PubMed Web of Science ®Google Scholar
• Hastie AT, Moore WC, Li H, Rector BM, Ortega VE, Pascual RM, et al. Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects. J Allergy Clin Immunol 2013; 132(1):72–80.
   PubMed Web of Science ®Google Scholar
• Singh D, Edwards L, Tal-Singer R, Rennard S. Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study. Respir Res 2010; 11:77.
   PubMed Web of Science ®Google Scholar
• Eltboli O, Brightling CE. Eosinophils as diagnostic tools in chronic lung disease. Expert Rev Respir Med 2013; 7(1):33–42.
   PubMed Web of Science ®Google Scholar
• Bafadhel M, McKenna S, Terry S, Mistry V, Reid C, Haldar P, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med 2011; 184(6):662–671.
   PubMed Web of Science ®Google Scholar
• Saltürk C, Karakurt Z, Adiguzel N, Kargin F, Sari R, Celik ME, et al. Does eosinophilic COPD exacerbation have a better patient outcome than non-eosinophilic in the intensive care unit? Int J Chron Obstruct Pulmon Dis 2015; 10:1837–1846.
   PubMed Web of Science ®Google Scholar
• Roy K, Smith J, Kolsum U, Borrill Z, Vestbo J, Singh D. COPD phenotype description using principal components analysis. Respir Res 2009; 10:41.
   PubMed Web of Science ®Google Scholar
• Simpson JL, Scott R, Boyle MJ, Gibson PG. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology 2006; 11(1):54–61.
   PubMed Web of Science ®Google Scholar
• Leigh R, Pizzichini MMM, Morris MM, Maltais F, Hargreave FE, Pizzichini E. Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment. Eur Respir J 2006; 27(5):964–971.
   PubMed Web of Science ®Google Scholar
• Grabcanovic-Musija F, Obermayer A, Stoiber W, Krautgartner W-D, Steinbacher P, Winterberg N, et al. Neutrophil extracellular trap (NET) formation characterises stable and exacerbated COPD and correlates with airflow limitation. Respir Res 2015; 16:59.
   PubMed Web of Science ®Google Scholar
• Faurschou M, Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect Inst Pasteur 2003; 5(14):1317–1327.
   PubMed Web of Science ®Google Scholar
• Chaudhuri R, McSharry C, Spears M, Brady J, Grierson C, Messow CM, et al. Sputum matrix metalloproteinase-9 is associated with the degree of emphysema on computed tomography in COPD. Transl Respir Med 2013; 1(1):11.
   PubMedGoogle Scholar
• Vlahos R, Wark PAB, Anderson GP, Bozinovski S. Glucocorticosteroids differentially regulate MMP-9 and neutrophil elastase in COPD. PloS One 2012; 7(3):e33277.
   PubMed Web of Science ®Google Scholar
• Mercer PF, Shute JK, Bhowmik A, Donaldson GC, Wedzicha JA, Warner JA. MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation. Respir Res 2005; 6:151.
   PubMed Web of Science ®Google Scholar